Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-186928
Filing Date
2026-04-28
Accepted
2026-04-28 16:05:21
Documents
16
Period of Report
2026-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A alec-20260421.htm   iXBRL DEF 14A 1903027
2 GRAPHIC img213373948_0.jpg GRAPHIC 110934
3 GRAPHIC img213373948_1.gif GRAPHIC 159811
4 GRAPHIC img213373948_2.jpg GRAPHIC 3720364
5 GRAPHIC img213373948_3.jpg GRAPHIC 1714193
  Complete submission text file 0001193125-26-186928.txt   16768251

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20260421.xsd EX-101.SCH 27225
19 EXTRACTED XBRL INSTANCE DOCUMENT alec-20260421_htm.xml XML 309954
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38792 | Film No.: 26907577
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)